Capital Point Ltd. (TASE:CPTP) sold 1% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) for $3.4 million on June 29, 2016. Capital Point sold about 0.22 million Neuroderm’s shares for $15.6 per share. The Audit Committee of Capital Point approved the transaction. Capital Point Ltd. (TASE:CPTP) completed the sale of 2.7% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) on June 29, 2016.